Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic, Functional, Metabolic and Transcriptomic Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

NCT06154668 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT06154668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06154668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic, Functional, Metabolic and Transcriptomic Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
January 17, 2024
Completion date
January 31, 2031
Enrollment
707 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma